Home / Startup / Le startup / Alia Therapeutics

Alia Therapeutics

Alia Therapeutics, the first Italian CRISPR-company, is developing innovative therapeutic approaches to defeat previously incurable genetic diseases. Alia's genome editing technology enables the modification of cellular genomes with unprecedented specificity, coupled with safe and efficient delivery to target cells.

Alia Therapeutics
Sector
Phase
Idea
Startup

Subscribe to our newsletter to receive
our news right in your inbox!